Ethyl Eicosapentaenoic Acid

DRUG2 trials

Sponsors

National Institute of Mental Health (NIMH), New York State Psychiatric Institute

Conditions

Bipolar DisorderInvolutional DepressionMood Disorder

Phase 2

Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial

CompletedNCT00001146

National Institute of Mental Health (NIMH)Bipolar Disorder, Involutional Depression, Mood Disorder

Start: 1999-10-31End: 2002-08-31Target: 240Updated: 2008-03-04

Phase 4

A PET Study With [11C]PBR-28 and an Experimental Medication, Ethyl Eicosapentaenoic Acid

WithdrawnNCT04811404

New York State Psychiatric InstituteBipolar Disorder

Start: 2021-03-19End: 2022-07-01Updated: 2022-10-14